Safety Study of Pyridostigmine in Heart Failure
NCT01415921
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
33
Enrollment
OTHER
Sponsor class
Conditions
Heart Failure
Interventions
DRUG:
Pyridostigmine Bromide
Sponsor
NYU Langone Health
Collaborators
[object Object]
[object Object]
[object Object]